Navegar por autor "Bóveda Fontán, María Dolores"

Antibodies against Carbamylated Proteins (ANTI-CARP), a new type of autoantibody, in spanish patients with rheumatoid arthritis

2014- Gómez-Reino Carnota, Juan Jesús; González Martínez-Pedrayo, Antonio; Montes Martínez, Ariana María; Pérez Pampín, Eva; Bóveda Fontán, María Dolores [et al.]

Clinical and metabolic findings in patients with methionine adenosyltransferase I/III deficiency detected by newborn screening

2013- Couce Pico, María Luz; Castiñeiras Ramos, Daisy E; Bóveda Fontán, María Dolores; Fraga Bermúdez, José María; Fernández Marmiesse, Ana [et al.]

Clinical and metabolic findings in patients with methionine adenosyltransferase I/III deficiency detected by newborn screening (vol 110, pg 218, 2013)

2015- Couce Pico, María Luz; Castiñeiras Ramos, Daisy E; Bóveda Fontán, María Dolores; Fraga Bermúdez, José María; Fernández Marmiesse, Ana [et al.]

Clinical and Tissue Specificity of Antibodies Against Carbamylated Proteins in Patients with Rheumatoid Arthritis.

2014- Gómez-Reino Carnota, Juan Jesús; González Martínez-Pedrayo, Antonio; Montes Martínez, Ariana María; Pérez Pampín, Eva; Bóveda Fontán, María Dolores [et al.]

Corrigendum to

2015- Leis Trabazo, María Rosaura; Couce Pico, María Luz; Bóveda Fontán, María Dolores; Fraga Bermúdez, José María

Descripción de una cristaluria por amoxicilina

2013- Bóveda Fontán, María Dolores; Lojo Rocamonde, Santiago; Soto Fernández, Sonia

Determinación de ácido etilendiaminotetraacético por espectrometría de masas en tándem en muestras de sangre impregnadas en papel. Utilidad en la medida de tirotropina para cribado neonatal de hipotiroidismo congénito

2012- Castiñeiras Ramos, Daisy E; Bóveda Fontán, María Dolores; Cocho de Juan, José Ángel; Fraga Bermúdez, José María; Pérez Suarez, Luis Fernando; [et al.]

Development of electrospray ionization tandem mass spectrometry methods for the study of a high number of urine markers of inborn errors of metabolism

2012- Couce Pico, María Luz; Rebollido Fernández, María; Castiñeiras Ramos, Daisy E; Bóveda Fontán, María Dolores; Cocho de Juan, José Ángel; [et al.]

Evaluation and long-term follow-up of infants with inborn errors of metabolism identified in an expanded screening programme

2011- Couce Pico, María Luz; Baña Souto, Ana Maria; Castiñeiras Ramos, Daisy E; Bóveda Fontán, María Dolores; Cocho de Juan, José Ángel; [et al.]

Evolution of patients with methionine adenosyltransferase (MAT) I/III deficiency detected by neonatal screening in Spain

2013- Couce Pico, María Luz; Castiñeiras Ramos, Daisy E; Bóveda Fontán, María Dolores; Fraga Bermúdez, José María; Iglesias Rodríguez, Agustín Javier [et al.]

Genotype-phenotype correlation in MCADD detected by newborn screening and relevance of L-carnitine supplemention in patients homozygous for the common c.985A>G mutation

2013- Couce Pico, María Luz; Castiñeiras Ramos, Daisy E; Bóveda Fontán, María Dolores; Cocho de Juan, José Ángel; García Nimo, Laura; [et al.]

Glutaric aciduria type I: outcome of patients with early- versus late-diagnosis

2013- Couce Pico, María Luz; Castiñeiras Ramos, Daisy E; Bóveda Fontán, María Dolores; Cocho de Juan, José Ángel; Fraga Bermúdez, José María; [et al.]

Inborn errors of metabolism in a neonatology unit: Impact and long-term results

2011- Couce Pico, María Luz; Baña Souto, Ana Maria; Bóveda Fontán, María Dolores; Fraga Bermúdez, José María; Pérez Muñuzuri, Alejandro; [et al.]

Long-term pharmacological management of phenylketonuria, including patients below the age of 4 years.

2012- Couce Pico, María Luz; Bóveda Fontán, María Dolores; Fraga Bermúdez, José María; Pérez Muñuzuri, Alejandro

Molecular epidemiology and BH4-responsiveness in patients with phenylalanine hydroxylase deficiency from Galicia region of Spain

2013- Couce Pico, María Luz; Bóveda Fontán, María Dolores; Fraga Bermúdez, José María; Mirás Veiga, Alicia; Fernández Marmiesse, Ana [et al.]

Newborn screening improves neurologic evolution and quality of life in maple syrup urine disease patients

2015- Couce Pico, María Luz; Bóveda Fontán, María Dolores; De Castro López, María José; Sánchez Pintos, Paula; Camba Caride, María Jesús [et al.]

Risk factors for developing mineral bone disease in phenylketonuric patients

2013- Leis Trabazo, María Rosaura; Couce Pico, María Luz; Bóveda Fontán, María Dolores; Fraga Bermúdez, José María; Mera Varela, Antonio; [et al.]

Risk factors for developing mineral bone disease in phenylketonuric patients (vol 108, pg 149, 2013)

2015- Leis Trabazo, María Rosaura; Couce Pico, María Luz; Bóveda Fontán, María Dolores; Fraga Bermúdez, José María; Mera Varela, Antonio; [et al.]

The early detection of Salla disease through second-tier tests in newborn screening: how to face incidental findings

2014- Couce Pico, María Luz; Castiñeiras Ramos, Daisy E; Bóveda Fontán, María Dolores; Fraga Bermúdez, José María; Fernández Marmiesse, Ana [et al.]

Repositorio digital RUNA

Navegar por autor "Bóveda Fontán, María Dolores"

Antibodies against Carbamylated Proteins (ANTI-CARP), a new type of autoantibody, in spanish patients with rheumatoid arthritis ﻿

Clinical and metabolic findings in patients with methionine adenosyltransferase I/III deficiency detected by newborn screening ﻿

Clinical and metabolic findings in patients with methionine adenosyltransferase I/III deficiency detected by newborn screening (vol 110, pg 218, 2013) ﻿

Clinical and Tissue Specificity of Antibodies Against Carbamylated Proteins in Patients with Rheumatoid Arthritis. ﻿

Corrigendum to ﻿

Descripción de una cristaluria por amoxicilina ﻿

Determinación de ácido etilendiaminotetraacético por espectrometría de masas en tándem en muestras de sangre impregnadas en papel. Utilidad en la medida de tirotropina para cribado neonatal de hipotiroidismo congénito ﻿

Development of electrospray ionization tandem mass spectrometry methods for the study of a high number of urine markers of inborn errors of metabolism ﻿

Evaluation and long-term follow-up of infants with inborn errors of metabolism identified in an expanded screening programme ﻿

Evolution of patients with methionine adenosyltransferase (MAT) I/III deficiency detected by neonatal screening in Spain ﻿

Genotype-phenotype correlation in MCADD detected by newborn screening and relevance of L-carnitine supplemention in patients homozygous for the common c.985A>G mutation ﻿

Glutaric aciduria type I: outcome of patients with early- versus late-diagnosis ﻿

Inborn errors of metabolism in a neonatology unit: Impact and long-term results ﻿

Long-term pharmacological management of phenylketonuria, including patients below the age of 4 years. ﻿

Molecular epidemiology and BH4-responsiveness in patients with phenylalanine hydroxylase deficiency from Galicia region of Spain ﻿

Newborn screening improves neurologic evolution and quality of life in maple syrup urine disease patients ﻿

Risk factors for developing mineral bone disease in phenylketonuric patients ﻿

Risk factors for developing mineral bone disease in phenylketonuric patients (vol 108, pg 149, 2013) ﻿

The early detection of Salla disease through second-tier tests in newborn screening: how to face incidental findings ﻿

Antibodies against Carbamylated Proteins (ANTI-CARP), a new type of autoantibody, in spanish patients with rheumatoid arthritis

Clinical and metabolic findings in patients with methionine adenosyltransferase I/III deficiency detected by newborn screening

Clinical and metabolic findings in patients with methionine adenosyltransferase I/III deficiency detected by newborn screening (vol 110, pg 218, 2013)

Clinical and Tissue Specificity of Antibodies Against Carbamylated Proteins in Patients with Rheumatoid Arthritis.

Corrigendum to

Descripción de una cristaluria por amoxicilina

Determinación de ácido etilendiaminotetraacético por espectrometría de masas en tándem en muestras de sangre impregnadas en papel. Utilidad en la medida de tirotropina para cribado neonatal de hipotiroidismo congénito

Development of electrospray ionization tandem mass spectrometry methods for the study of a high number of urine markers of inborn errors of metabolism

Evaluation and long-term follow-up of infants with inborn errors of metabolism identified in an expanded screening programme

Evolution of patients with methionine adenosyltransferase (MAT) I/III deficiency detected by neonatal screening in Spain

Genotype-phenotype correlation in MCADD detected by newborn screening and relevance of L-carnitine supplemention in patients homozygous for the common c.985A>G mutation

Glutaric aciduria type I: outcome of patients with early- versus late-diagnosis

Inborn errors of metabolism in a neonatology unit: Impact and long-term results

Long-term pharmacological management of phenylketonuria, including patients below the age of 4 years.

Molecular epidemiology and BH4-responsiveness in patients with phenylalanine hydroxylase deficiency from Galicia region of Spain

Newborn screening improves neurologic evolution and quality of life in maple syrup urine disease patients

Risk factors for developing mineral bone disease in phenylketonuric patients

Risk factors for developing mineral bone disease in phenylketonuric patients (vol 108, pg 149, 2013)

The early detection of Salla disease through second-tier tests in newborn screening: how to face incidental findings